Brought to you by 
Zyomyx raises $32.6mm in Series D financing
07 Dec 2000
Executive Summary
Zyomyx (protein biochips) brought in about $32.6mm in a Series D private financing of 8.2mm preferred shares to new investors Credit Suisse First Boston, Morgan Stanley Dean Witter, Softbank, China Development Investment Bank, Sumitomo Corp., Invus, NIF Ventures, MDS Proteomics, and Japanese health care company Fujirebio (Zyomyx's development partner).
Deal Industry
- In Vitro Diagnostics
- Pharmaceuticals
- Research, Analytical Equipment & Supplies
-
Biotechnology
- Large Molecule
- Nanotechnology, Chips, etc.
-
Drug Discovery Tools
- Bioinformatics
Deal Status
- Final
Deal Type
-
Financing
- Venture Financing
Already a Biomedtracker subscriber?
You have access to the full deal record through your subscription
Want to become a subscriber?
Subscribers get more deal details, updates, deal financials and deal products.
Questions?
Questions?
Please contact Sales at: (212) 520-2765 or email [email protected]
Related Companies
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Zyomyx raises $32.6mm in Series D financing
Email Deal
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice